Pear Therapeutics- Warrants (01/12/2026) Overview

Pear Therapeutics- Warrants (01/12/2026) Selling, General & Admin

Selling, General & Admin expenses for PEARW.

Quarterly SG&A Expenses

$18.04M

↓ 73.32% YoY

As of Dec 31, 2022

Annual SG&A Expenses (TTM)

$79.55M

↑ 17.65% YoY

Trailing 12 months ending Dec 31, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin